Good to see someone else actually reviewing the published numbers and looking at prospective eps. I think 6 is the minimum, with about an 8% fall in Q4 sales. Plenty of scope for higher E, not sure they would payout more than 6 though.
Wazz
Ann: Acrux presents at BioTrinity-ACR.AX, page-44
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $15.98M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.5¢ | $3.097K | 56.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 168800 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 185000 | 2 |
View Market Depth
| Last trade - 13.06pm 10/09/2024 (20 minute delay) ? |
| ACR (ASX) Chart |